Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA, Single-Stranded | 1 | 2019 | 407 | 0.770 |
Why?
|
| Interleukin-2 | 4 | 2017 | 1923 | 0.610 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1204 | 0.490 |
Why?
|
| Immunotherapy | 3 | 2018 | 2700 | 0.400 |
Why?
|
| Colorectal Neoplasms | 3 | 2018 | 5475 | 0.310 |
Why?
|
| Melanoma | 3 | 2017 | 4982 | 0.240 |
Why?
|
| Interleukin-12 | 1 | 2002 | 556 | 0.230 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2017 | 2397 | 0.220 |
Why?
|
| DNA Mismatch Repair | 2 | 2018 | 271 | 0.210 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 560 | 0.210 |
Why?
|
| Microsatellite Instability | 2 | 2018 | 636 | 0.190 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 836 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2487 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 1700 | 0.160 |
Why?
|
| Cytokines | 1 | 2009 | 6598 | 0.150 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 3365 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 4680 | 0.130 |
Why?
|
| Leukemia | 1 | 2019 | 1394 | 0.130 |
Why?
|
| Chromosomes | 1 | 2014 | 561 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 9638 | 0.120 |
Why?
|
| Protein Conformation | 1 | 2019 | 4042 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2019 | 1268 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2002 | 2509 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2002 | 4261 | 0.120 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 4902 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2019 | 1785 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2009 | 448 | 0.100 |
Why?
|
| Half-Life | 1 | 2009 | 699 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 12429 | 0.100 |
Why?
|
| Protein Binding | 1 | 2019 | 9795 | 0.090 |
Why?
|
| Cancer Vaccines | 1 | 2012 | 929 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2009 | 1622 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2002 | 7883 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 9485 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2018 | 53492 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 12913 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2014 | 3482 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7380 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2002 | 529 | 0.060 |
Why?
|
| Lectins | 1 | 2002 | 542 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2002 | 890 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 12144 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 7025 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 675 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2019 | 213 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2002 | 23110 | 0.050 |
Why?
|
| Brain | 2 | 2015 | 21431 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 957 | 0.050 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 233 | 0.050 |
Why?
|
| Biopsy | 1 | 2009 | 6236 | 0.050 |
Why?
|
| Survival Rate | 3 | 2018 | 12252 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4389 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 567 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11505 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 550 | 0.040 |
Why?
|
| Aged | 7 | 2018 | 142944 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 10261 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 9744 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 656 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3189 | 0.040 |
Why?
|
| Female | 10 | 2019 | 336014 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2017 | 10116 | 0.040 |
Why?
|
| Humans | 11 | 2018 | 598780 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6159 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2019 | 1314 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2002 | 2634 | 0.030 |
Why?
|
| Adult | 7 | 2018 | 191039 | 0.030 |
Why?
|
| Myoblasts | 1 | 2014 | 253 | 0.030 |
Why?
|
| Middle Aged | 7 | 2018 | 194743 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2002 | 4335 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2019 | 3026 | 0.030 |
Why?
|
| Muscle Development | 1 | 2014 | 300 | 0.030 |
Why?
|
| Male | 9 | 2019 | 318100 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 225 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 17930 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2951 | 0.030 |
Why?
|
| Base Sequence | 2 | 2015 | 14101 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 36863 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 52513 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 2428 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3867 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 9599 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 1485 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4394 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 20131 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 467 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14849 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 2094 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9190 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 40255 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 1581 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2011 | 870 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2011 | 1545 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3277 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4573 | 0.020 |
Why?
|
| Young Adult | 3 | 2017 | 46924 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6838 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1571 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 4101 | 0.020 |
Why?
|
| Animals | 4 | 2019 | 164731 | 0.020 |
Why?
|
| Mice | 3 | 2015 | 76804 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 2296 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 5047 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 6649 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 4173 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21597 | 0.010 |
Why?
|
| Aging | 1 | 2019 | 7735 | 0.010 |
Why?
|
| Genomics | 1 | 2014 | 4056 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 11574 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 20665 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 17790 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 12224 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 11673 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 34218 | 0.010 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_